Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus
about
Chemokines and Chemokine Receptors in the Development of Lupus NephritisClinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue DiseasesAnti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue diseaseCCL2 disrupts the adherens junction: implications for neuroinflammationCytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes.Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.Neuropsychiatric Symptoms in LupusAltered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression.Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).Developments in the scientific understanding of lupus.Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.Association of the -2510A/G chemokine (C-C motif) ligand 2 polymorphism with knee osteoarthritis in a Korean population.
P2860
Q26741199-117A635A-183D-4E39-9FD6-83587C0234A7Q26773164-A0E1CC18-1933-48B5-98CC-E822D525EAABQ28290942-DCA5A391-F3F1-4D3C-A09C-8CD765D21CABQ30523821-758ED01F-56BA-43FD-BD77-782F6447A3C2Q33628713-1E5431B3-275A-4AE4-B084-8D62299D5C2BQ33788323-5E62366A-F600-41D0-A43D-79A6533DD0F9Q34054877-82A8D067-D096-470C-8A72-E22B32DC1AB9Q34459628-B1BAB818-2116-4402-A679-6845C7F48126Q35743736-F972C747-BB59-4866-947F-B811E2FD5D16Q35902490-B081A553-76AB-4A78-BDA4-476DA7DA37C8Q36993221-E0731371-2B9C-4703-875A-BDC20CBB7CE4Q37351240-512275A0-D99B-4B10-8413-B672BC953F5FQ37982064-B3C19E1C-7DBE-4BC3-984B-7BF8AC8E0D94Q38774697-8B44D2E2-4FAF-4F2C-BEEC-CB2AF289A91CQ40804722-3DC7E6F1-1C13-44E2-BA94-8D1E71646EACQ42955594-FE8E76BC-EFE0-4782-ABC3-285A96B72D68Q47657635-D1712CF2-71E6-4B9F-83EC-FE4C7BEDE0E7Q53563548-01E19062-81A8-4306-A4CF-172AE41C7AC1
P2860
Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@ast
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@en
type
label
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@ast
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@en
prefLabel
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@ast
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@en
P2093
P2860
P356
P1476
Raised monocyte chemotactic pr ...... ts with neuropsychiatric lupus
@en
P2093
Kamatani N
Kamitsuji S
Momohara S
Taniguchi A
Yamanaka H
P2860
P304
P356
10.1136/ARD.2005.041640
P407
P577
2006-02-01T00:00:00Z